scispace - formally typeset
M

Mark L. Dallas

Researcher at University of Reading

Publications -  74
Citations -  3065

Mark L. Dallas is an academic researcher from University of Reading. The author has contributed to research in topics: Heme oxygenase & Chemistry. The author has an hindex of 28, co-authored 66 publications receiving 2604 citations. Previous affiliations of Mark L. Dallas include University of Leeds.

Papers
More filters
Journal ArticleDOI

Molecular Targets of Cannabidiol in Neurological Disorders

TL;DR: CBD was found to act upon a number of targets that are linked to neurological therapeutics but that its actions were not consistent with modulation of such targets that would derive a therapeutically beneficial outcome.
Journal ArticleDOI

Amp-activated protein kinase mediates carotid body excitation by hypoxia

TL;DR: A central role for AMPK is demonstrated in stimulus-response coupling by hypoxia and a link between metabolic stress and ion channel regulation in an O2-sensing system is identified for the first time.
Journal ArticleDOI

Hypoxia and Neurodegeneration

TL;DR: The molecular and cellular responses toHypoxia contribute to the understanding of the clinical association of hypoxia and increased incidence of AD, and it remains to be determined whether inhibition of one or more of the effects of Hypoxia may be of benefit in arresting the development of this neurodegenerative disease.
Journal ArticleDOI

Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase

TL;DR: It is shown that pharmacological restoration of AMPK activity not only abrogates the lipid accumulation observed in virus-infected and subgenomic replicon-harboring cells but also efficiently inhibits viral replication.
Journal ArticleDOI

Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species.

TL;DR: The data indicate that the cardioprotective effects of HO-1 activity may be attributable to an inhibitory action of CO on cardiac L-type Ca2+ channels, which arises from the ability of CO to promote generation of reactive oxygen species from complex III of mitochondria.